_id
69109a69ccc777a4e85d5cd9
Ticker
EXOZ
Name
eXoZymes, Inc.
Exchange
NASDAQ
Address
750 Royal Oaks Drive, Monrovia, CA, United States, 91016
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.exozymes.com
Description
eXoZymes, Inc. operates as a development stage biotechnology company. The company focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
Last Close
11.0263
Volume
1022
Current Price
10.5
Change
0.09
Last Updated
2026-01-03T11:21:04.850Z
Image
data:image/webp;base64,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
Ipo Date
2024-11-13T00:00:00.000Z
Market Cap
91421024
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
71603
Gross Profit
-71603
Operating Expenses
2450605
Operating Income
-2522208
Interest Expense
59185
Pretax Income
-2286991
Net Income
-2286991
Eps
-0.27267471459656023
Dividends Per Share
-
Shares Outstanding
8387250
Income Tax Expense
-
EBITDA
-2215388
Operating Margin
-
Total Other Income Expense Net
235217
Cash
5098687
Short Term Investments
-
Receivables
302643
Inventories
-
Total Current Assets
5606050
Property Plant Equipment
2007173
Total Assets
7719049
Payables
904353
Short Term Debt
316924
Long Term Debt
-
Total Liabilities
2344627
Equity
5374422
Bs_currency_symbol
USD
Depreciation
71603
Change In Working Capital
-77208
Cash From Operations
-1856708
Capital Expenditures
13310
Cash From Investing
-13308
Cash From Financing
-17155
Net Change In Cash
-1887171
Cf_currency_symbol
USD
PE
-
PB
16.386157432371334
ROE
-42.55324572577293
ROA
-29.62788550765774
FCF
-1870018
Fcf Percent
-
Piotroski FScore
1
Health Score
35
Deep Value Investing Score
3
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
71603
Quarters > 0 > income Statement > gross Profit
-71603
Quarters > 0 > income Statement > operating Expenses
2450605
Quarters > 0 > income Statement > operating Income
-2522208
Quarters > 0 > income Statement > interest Expense
59185
Quarters > 0 > income Statement > pretax Income
-2286991
Quarters > 0 > income Statement > net Income
-2286991
Quarters > 0 > income Statement > eps
-0.27267471459656023
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
8387250
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-2215388
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
235217
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
5098687
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
302643
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
5606050
Quarters > 0 > balance Sheet > property Plant Equipment
2007173
Quarters > 0 > balance Sheet > total Assets
7719049
Quarters > 0 > balance Sheet > payables
904353
Quarters > 0 > balance Sheet > short Term Debt
316924
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
2344627
Quarters > 0 > balance Sheet > equity
5374422
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-2286991
Quarters > 0 > cash Flow > depreciation
71603
Quarters > 0 > cash Flow > change In Working Capital
-77208
Quarters > 0 > cash Flow > cash From Operations
-1856708
Quarters > 0 > cash Flow > capital Expenditures
13310
Quarters > 0 > cash Flow > cash From Investing
-13308
Quarters > 0 > cash Flow > cash From Financing
-17155
Quarters > 0 > cash Flow > net Change In Cash
-1887171
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.27267471459656023
Quarters > 0 > ratios > PB
16.386157432371334
Quarters > 0 > ratios > ROE
-42.55324572577293
Quarters > 0 > ratios > ROA
-29.62788550765774
Quarters > 0 > ratios > FCF
-1870018
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
35
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
72256
Quarters > 1 > income Statement > gross Profit
-72256
Quarters > 1 > income Statement > operating Expenses
2475789
Quarters > 1 > income Statement > operating Income
-2548045
Quarters > 1 > income Statement > interest Expense
76557
Quarters > 1 > income Statement > pretax Income
-2360286
Quarters > 1 > income Statement > net Income
-2360286
Quarters > 1 > income Statement > eps
-0.28174899564475997
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
8377265
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-2288032
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
187759
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
6985858
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
257753
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
7531030
Quarters > 1 > balance Sheet > property Plant Equipment
2145879
Quarters > 1 > balance Sheet > total Assets
9676909
Quarters > 1 > balance Sheet > payables
930629
Quarters > 1 > balance Sheet > short Term Debt
286314
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
2441204
Quarters > 1 > balance Sheet > equity
7235705
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-2360286
Quarters > 1 > cash Flow > depreciation
-97661
Quarters > 1 > cash Flow > change In Working Capital
189165
Quarters > 1 > cash Flow > cash From Operations
-1537999
Quarters > 1 > cash Flow > capital Expenditures
50573
Quarters > 1 > cash Flow > cash From Investing
-30874
Quarters > 1 > cash Flow > cash From Financing
43254
Quarters > 1 > cash Flow > net Change In Cash
-1525619
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.28174899564475997
Quarters > 1 > ratios > PB
12.156560072584496
Quarters > 1 > ratios > ROE
-32.61998658043688
Quarters > 1 > ratios > ROA
-24.39090829520046
Quarters > 1 > ratios > FCF
-1588572
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
35
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
70503
Quarters > 2 > income Statement > gross Profit
-70503
Quarters > 2 > income Statement > operating Expenses
1880225
Quarters > 2 > income Statement > operating Income
-1950728
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-1856421
Quarters > 2 > income Statement > net Income
-1856421
Quarters > 2 > income Statement > eps
-0.22185267112900509
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
8367810
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-1880225
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
94307
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
8511477
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
595160
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
9418847
Quarters > 2 > balance Sheet > property Plant Equipment
2106845
Quarters > 2 > balance Sheet > total Assets
11525692
Quarters > 2 > balance Sheet > payables
1071802
Quarters > 2 > balance Sheet > short Term Debt
236795
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
2644061
Quarters > 2 > balance Sheet > equity
8881631
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-1856421
Quarters > 2 > cash Flow > depreciation
70503
Quarters > 2 > cash Flow > change In Working Capital
341249
Quarters > 2 > cash Flow > cash From Operations
-1133533
Quarters > 2 > cash Flow > capital Expenditures
31046
Quarters > 2 > cash Flow > cash From Investing
-31046
Quarters > 2 > cash Flow > cash From Financing
-43254
Quarters > 2 > cash Flow > net Change In Cash
-1207833
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.22185267112900509
Quarters > 2 > ratios > PB
9.892552955645195
Quarters > 2 > ratios > ROE
-20.901802833285913
Quarters > 2 > ratios > ROA
-16.10680729625605
Quarters > 2 > ratios > FCF
-1164579
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
35
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
137756
Quarters > 3 > income Statement > cost Of Revenue
67567
Quarters > 3 > income Statement > gross Profit
-67567
Quarters > 3 > income Statement > operating Expenses
1915749
Quarters > 3 > income Statement > operating Income
-1983316
Quarters > 3 > income Statement > interest Expense
32965
Quarters > 3 > income Statement > pretax Income
-1838117
Quarters > 3 > income Statement > net Income
-1835974
Quarters > 3 > income Statement > eps
-0.22590072113305334
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
8127349
Quarters > 3 > income Statement > income Tax Expense
-2143
Quarters > 3 > income Statement > EBITDA
-1770547
Quarters > 3 > income Statement > operating Margin
-1439.7311187897442
Quarters > 3 > income Statement > total Other Income Expense Net
145199
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
9719310
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
737282
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
10820382
Quarters > 3 > balance Sheet > property Plant Equipment
2214022
Quarters > 3 > balance Sheet > total Assets
13034404
Quarters > 3 > balance Sheet > payables
924252
Quarters > 3 > balance Sheet > short Term Debt
230027
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
2613629
Quarters > 3 > balance Sheet > equity
10420775
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-1835974
Quarters > 3 > cash Flow > depreciation
67567
Quarters > 3 > cash Flow > change In Working Capital
-4250264
Quarters > 3 > cash Flow > cash From Operations
-5707527
Quarters > 3 > cash Flow > capital Expenditures
210406
Quarters > 3 > cash Flow > cash From Investing
-210407
Quarters > 3 > cash Flow > cash From Financing
15403309
Quarters > 3 > cash Flow > net Change In Cash
9485375
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.22590072113305334
Quarters > 3 > ratios > PB
8.189137995974388
Quarters > 3 > ratios > ROE
-17.618401702368587
Quarters > 3 > ratios > ROA
-14.085599924630232
Quarters > 3 > ratios > FCF
-5917933
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-42.95952989343477
Quarters > 3 > health Score
26
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
267382
Annuals > 0 > income Statement > gross Profit
-267382
Annuals > 0 > income Statement > operating Expenses
5664723
Annuals > 0 > income Statement > operating Income
-5932105
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-5861335
Annuals > 0 > income Statement > net Income
-5861335
Annuals > 0 > income Statement > eps
-0.721186576336269
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
8127349
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-5593949
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
70770
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
9719310
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
737282
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
10820382
Annuals > 0 > balance Sheet > property Plant Equipment
2214022
Annuals > 0 > balance Sheet > total Assets
13034404
Annuals > 0 > balance Sheet > payables
924252
Annuals > 0 > balance Sheet > short Term Debt
230027
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
2613629
Annuals > 0 > balance Sheet > equity
10420775
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-5861335
Annuals > 0 > cash Flow > depreciation
267382
Annuals > 0 > cash Flow > change In Working Capital
-4017940
Annuals > 0 > cash Flow > cash From Operations
-8505650
Annuals > 0 > cash Flow > capital Expenditures
396451
Annuals > 0 > cash Flow > cash From Investing
-359216
Annuals > 0 > cash Flow > cash From Financing
18517643
Annuals > 0 > cash Flow > net Change In Cash
9652777
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.721186576336269
Annuals > 0 > ratios > PB
8.571297769119859
Annuals > 0 > ratios > ROE
-56.246632328209756
Annuals > 0 > ratios > ROA
-44.968185733693694
Annuals > 0 > ratios > FCF
-8902101
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
27
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
1796222
Annuals > 1 > income Statement > operating Income
-1796222
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-1996122
Annuals > 1 > income Statement > net Income
-2038389
Annuals > 1 > income Statement > eps
-0.25080613617060127
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
8127349
Annuals > 1 > income Statement > income Tax Expense
42267
Annuals > 1 > income Statement > EBITDA
-1599285
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-199900
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
66533
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
882319
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
1213614
Annuals > 1 > balance Sheet > property Plant Equipment
2344895
Annuals > 1 > balance Sheet > total Assets
3558509
Annuals > 1 > balance Sheet > payables
702911
Annuals > 1 > balance Sheet > short Term Debt
224988
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
3942828
Annuals > 1 > balance Sheet > equity
-384319
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-2038389
Annuals > 1 > cash Flow > depreciation
196937
Annuals > 1 > cash Flow > change In Working Capital
220314
Annuals > 1 > cash Flow > cash From Operations
-1180870
Annuals > 1 > cash Flow > capital Expenditures
288712
Annuals > 1 > cash Flow > cash From Investing
-311167
Annuals > 1 > cash Flow > cash From Financing
1000000
Annuals > 1 > cash Flow > net Change In Cash
-492037
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.25080613617060127
Annuals > 1 > ratios > PB
-232.4099654453722
Annuals > 1 > ratios > ROE
530.3898584249023
Annuals > 1 > ratios > ROA
-57.282108883242955
Annuals > 1 > ratios > FCF
-1469582
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
147751
Annuals > 2 > income Statement > gross Profit
-147751
Annuals > 2 > income Statement > operating Expenses
1184916
Annuals > 2 > income Statement > operating Income
-1332667
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-1332569
Annuals > 2 > income Statement > net Income
-1396128
Annuals > 2 > income Statement > eps
-0.17178147511568656
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
8127349
Annuals > 2 > income Statement > income Tax Expense
63559
Annuals > 2 > income Statement > EBITDA
-1184818
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
98
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
558570
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
809532
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
1469239
Annuals > 2 > balance Sheet > property Plant Equipment
1216419
Annuals > 2 > balance Sheet > total Assets
2685658
Annuals > 2 > balance Sheet > payables
385796
Annuals > 2 > balance Sheet > short Term Debt
145003
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
1313126
Annuals > 2 > balance Sheet > equity
1372532
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-1396128
Annuals > 2 > cash Flow > depreciation
147751
Annuals > 2 > cash Flow > change In Working Capital
-190072
Annuals > 2 > cash Flow > cash From Operations
-1257096
Annuals > 2 > cash Flow > capital Expenditures
185983
Annuals > 2 > cash Flow > cash From Investing
-87210
Annuals > 2 > cash Flow > cash From Financing
1355070
Annuals > 2 > cash Flow > net Change In Cash
10764
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.17178147511568656
Annuals > 2 > ratios > PB
65.07649039148086
Annuals > 2 > ratios > ROE
-101.71915846042205
Annuals > 2 > ratios > ROA
-51.98457882574773
Annuals > 2 > ratios > FCF
-1443079
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
22
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
59405
Annuals > 3 > income Statement > gross Profit
-59405
Annuals > 3 > income Statement > operating Expenses
1233440
Annuals > 3 > income Statement > operating Income
-1292845
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-1209106
Annuals > 3 > income Statement > net Income
-1209106
Annuals > 3 > income Statement > eps
-0.14877003559217156
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
8127349
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-1149701
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
83739
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
547806
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
468353
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
1046345
Annuals > 3 > balance Sheet > property Plant Equipment
1299770
Annuals > 3 > balance Sheet > total Assets
2346115
Annuals > 3 > balance Sheet > payables
267296
Annuals > 3 > balance Sheet > short Term Debt
133485
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
1149028
Annuals > 3 > balance Sheet > equity
1197087
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-1209106
Annuals > 3 > cash Flow > depreciation
59405
Annuals > 3 > cash Flow > change In Working Capital
-536480
Annuals > 3 > cash Flow > cash From Operations
-1586720
Annuals > 3 > cash Flow > capital Expenditures
422586
Annuals > 3 > cash Flow > cash From Investing
-312254
Annuals > 3 > cash Flow > cash From Financing
2312420
Annuals > 3 > cash Flow > net Change In Cash
413446
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.14877003559217156
Annuals > 3 > ratios > PB
74.61409697874926
Annuals > 3 > ratios > ROE
-101.00402059332363
Annuals > 3 > ratios > ROA
-51.53651888334545
Annuals > 3 > ratios > FCF
-2009306
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
23
Valuation > metrics > PE
-0.27267471459656023
Valuation > metrics > PB
16.386157432371334
Valuation > final Score
20
Valuation > verdict
446.2% Overvalued
Profitability > metrics > ROE
-42.55324572577293
Profitability > metrics > ROA
-40.79505177442228
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.43625658721998384
Risk > metrics > Interest Coverage
-42.615662752386584
Risk > final Score
-110
Risk > verdict
High
Liquidity > metrics > Current Ratio
4.5903181669678546
Liquidity > metrics > Quick Ratio
4.5903181669678546
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-73
Prev Risks > 1
-268
Prev Risks > 2
-181
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:48:33.971Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-09-30
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.2727
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-12
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.28
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-12
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.22
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-31
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.24
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
eXoZymes, Inc. operates as a development stage biotechnology company. The company focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ACan SBA Communications Corporation stock attract ESG capital inflows - Quarterly Market Summary & Smart Swing Trading Alerts bollywoodhelpline.com
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of eXoZymes, Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.2727
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.